mycoplasma
pneumonia
mp
smallest
freeliv
organ
common
caus
upper
lower
respiratori
tract
infect
sanchezvarga
gomezduart
mp
pneumonia
mpp
caus
communityacquir
pneumonia
cap
children
even
higher
ratio
epidem
although
selflimit
diseas
case
develop
refractori
fulmin
pneumonia
threaten
live
children
wait
talkington
pathophysiolog
mp
infect
complex
underli
molecular
mechan
report
associ
mani
protein
mp
infect
thought
influenc
express
associ
protein
releas
bloodstream
differ
pathway
covani
et
al
sun
et
al
li
et
al
plasma
protein
includ
cytokin
growth
factor
extracellular
matrix
protein
solubl
mediat
essenti
mp
infect
term
pediatr
mpp
diagnosi
cultur
serolog
test
insensit
timeconsum
crossreact
children
daxboeck
et
al
long
et
al
therefor
appropri
rapid
accur
detect
mp
infect
clinic
practic
gener
detect
biomark
plasma
use
auxiliari
method
diagnosi
diseas
chen
et
al
meyer
sauteur
et
al
shu
et
al
recent
advanc
highthroughput
technolog
proteom
made
analysi
plasma
protein
possibl
li
et
al
proteom
analysi
use
labelfre
protocol
increasingli
perform
biomark
select
base
principl
special
mixtur
plasma
protein
present
differ
character
techniqu
wide
use
mani
diseas
includ
infecti
diseas
papadopoulo
et
al
ren
et
al
agranoff
et
al
hodgett
et
al
cancer
engwegen
et
al
vascular
diseas
pinet
et
al
zhang
et
al
hong
et
al
although
mani
protein
biomark
mpp
indic
proteom
specif
protein
use
discrimin
mpp
infect
diseas
especi
children
fulli
elucid
studi
analyz
fold
chang
protein
express
children
mpp
infecti
diseas
control
idc
healthi
control
hc
use
labelfre
quantit
proteom
liquid
chromatographymassmass
spectrometri
lcmsm
protein
identifi
could
distinguish
mpp
hc
idc
valid
enzymelink
immunosorb
assay
elisa
aim
studi
screen
potenti
protein
biomark
plasma
children
could
use
distinguish
mpp
hc
idc
studi
perform
beij
children
hospit
novemb
septemb
first
period
total
children
hospit
final
diagnosi
mpp
confirm
serum
sampl
use
pcr
elisa
enrol
symptom
children
includ
fever
acut
respiratori
symptom
cough
tachypnoea
difficult
breath
tamura
et
al
wang
et
al
seventeen
children
defin
idc
collect
accordingli
symptom
includ
respiratori
symptom
neg
mpp
immunoglobulin
ig
exclud
mpp
hc
group
subject
n
recruit
children
undergo
physic
examin
beij
children
hospit
novemb
may
patient
immunosuppress
receiv
immunosuppress
therapi
exclud
group
match
age
gender
ethnic
human
plasma
remov
igg
iga
albumin
antitrypsin
haptoglobin
transferrin
mix
togeth
group
divid
three
tube
test
respect
mix
sampl
suspend
phosphat
buffer
salin
pb
centrifug
g
min
suspend
lysi
buffer
urea
thiourea
centrifug
g
min
protein
extract
ultrason
sonic
precipit
trichloroacet
acid
min
ice
sampl
dilut
mm
final
concentr
mgml
sampl
mix
dtt
moll
min
dilut
iaa
moll
min
dark
digest
trypsin
h
digest
supernat
fraction
use
lcmsm
analysi
lee
et
al
peptid
mixtur
subject
nanoliquid
chromatographi
associ
ms
protein
identif
mass
analys
perform
use
lcmsm
system
consist
agil
quaternari
hplc
agil
usa
qexact
mass
spectromet
thermo
finnigan
germani
applic
distal
sourc
temperatur
rp
trap
column
thermo
easi
column
mm
reversephas
column
thermo
easi
column
trap
mm
use
desalt
separ
sampl
respect
mobil
phase
consist
hplcgrade
water
contain
formic
acid
fa
phase
b
consist
hplcgrade
acetonitril
acn
contain
fa
analyt
separ
run
flow
rate
nlmin
use
linear
gradient
phase
b
follow
min
min
min
lcmsm
analysi
repeat
three
time
reduc
technic
variat
lee
et
al
protein
identif
use
mascot
program
matrix
scienc
search
fragment
spectra
human
databas
full
ms
msm
spectra
search
error
six
part
per
million
ppm
ppm
set
respect
two
miss
cleavag
allow
peptid
mass
toler
set
da
fragment
mass
toler
set
ppm
variabl
modif
oxid
methionin
static
modif
carbamidomethyl
cystein
protein
identif
consid
valid
least
one
peptid
p
protein
satisfi
defin
criteria
reject
threshold
accept
msm
spectra
fals
discoveri
rate
fdr
maxquant
ms
analysi
softwar
use
estim
foldchang
level
identifi
protein
three
group
webaccess
resourc
version
use
determin
overrepresent
gene
ontolog
go
categori
classifi
basi
cellular
compon
cc
molecular
function
mf
biolog
process
bp
zhang
et
al
wu
et
al
signal
pathway
analysi
perform
use
tool
kyoto
encyclopedia
gene
genom
kegg
databas
http
wwwgenomejpkeggpathwayhtml
kanehisa
et
al
network
model
protein
interact
accord
known
proteinprotein
interact
made
use
retriev
interact
gene
string
elisa
use
quantifi
concentr
select
plasma
protein
human
precursor
raybiotech
human
kinetochoreassoci
protein
dldevelop
human
apolipoprotein
ci
precursor
raybiotech
human
annexin
isoform
abnova
faddlik
apoptosi
regul
isoform
cflar
dldevelop
elisa
kit
use
measur
chang
plasma
protein
level
mpp
n
hc
n
idc
n
group
elisa
perform
accord
kit
instruct
experi
independ
repeat
least
three
time
data
express
mean
sd
evalu
student
ttest
p
consid
statist
signific
statist
analysi
perform
use
metaboanalyst
biomark
analysi
classic
univari
receiv
oper
characterist
roc
curv
analys
gener
roc
curv
calcul
area
curv
auc
confid
interv
comput
optim
cutoff
given
featur
gener
perform
tabl
sensit
specif
confid
interv
differ
cutoff
perform
roc
curv
analys
perform
base
three
multivari
vector
machin
use
assess
diagnost
valu
candid
protein
research
approv
ethic
committe
beij
children
hospit
supplementari
tabl
written
inform
consent
collect
children
guardian
children
accord
declar
helsinki
local
ethic
committe
requir
plasma
collect
protocol
research
base
follow
standard
potenti
risk
minor
discomfort
minim
util
well
train
personnel
procedur
charg
written
inform
consent
provid
children
guardian
particip
right
decid
whether
particip
particip
studi
receiv
direct
benefit
propos
research
howev
benefit
societi
could
potenti
less
expens
faster
way
diagnos
seriou
diseas
begin
treatment
earlier
current
diagnost
method
select
period
children
mpp
enrol
studi
boy
mean
age
patient
mpp
group
year
rang
year
among
children
idc
group
caus
agent
includ
streptococcu
pneumonia
n
influenza
b
viru
n
escherichia
coli
n
mycobacterium
tuberculosi
n
haemophilu
n
epsteinbarr
viru
n
regard
patient
demograph
signific
differ
age
gender
identifi
among
mpp
hc
idc
group
verif
period
mpp
children
hc
idc
recruit
elisa
verif
signific
differ
age
gender
identifi
among
three
group
tabl
labelfre
quantit
proteom
coupl
lcmsm
analysi
use
compar
sampl
three
group
mpp
hc
idc
base
lcmsm
data
total
protein
identifi
analysi
result
show
protein
differ
mpp
group
hc
group
idc
group
respect
supplementari
tabl
overlap
protein
analyz
protein
downregul
protein
upregul
mpp
group
compar
hc
group
twentyon
protein
downregul
six
protein
upregul
mpp
group
compar
idc
group
figur
tabl
reveal
biofunct
relationship
among
protein
hierarch
cluster
base
pearson
correl
varianc
appli
r
studio
figur
show
hierarch
cluster
identifi
protein
increas
red
color
show
increas
protein
express
level
figur
strike
area
upregul
mpp
patient
indic
region
seri
protein
peak
red
color
go
annot
use
analyz
function
protein
classifi
three
categori
cc
mf
bp
visual
annot
gene
set
wego
use
plot
distribut
go
annot
differenti
identifi
protein
subcategor
main
hierarch
structur
go
classif
includ
cc
mf
bp
figur
supplementari
tabl
major
protein
cc
categori
cellular
part
organel
distribut
protein
mf
categori
mainli
relat
bind
catalysi
enzym
regul
molecular
transduc
transcript
regul
transport
protein
bp
categori
mainli
associ
cellular
process
metabol
process
cellular
compon
organ
biolog
regul
pigment
analysi
indic
identifi
protein
involv
go
categori
might
import
role
mp
infect
process
obtain
inform
regard
marker
pathway
analysi
conduct
use
kegg
use
standard
p
impact
factor
threshold
pathway
analysi
result
demonstr
camp
signal
pathway
p
proteoglycan
cancer
p
significantli
associ
mpp
infect
figur
supplementari
tabl
base
bioinformat
analysi
five
potenti
candid
biomark
cflar
select
verif
figur
supplementari
tabl
select
principl
base
follow
standard
high
fold
chang
repres
protein
associ
immun
infecti
diseas
present
trend
compar
hc
idc
signific
differ
cflar
level
observ
among
three
group
ratio
consist
trend
proteom
result
p
respect
shown
figur
level
protein
mpp
markedli
increas
compar
hc
idc
contrast
significantli
lower
level
two
protein
cflar
observ
mpp
group
compar
hc
idc
although
level
lower
mpp
group
compar
hc
group
differ
mpp
idc
patient
auc
sensit
specif
roc
curv
calcul
optim
cutoff
three
differ
protein
shown
tabl
comparison
mpp
patient
hc
show
largest
auc
sensit
specif
comparison
mpp
idc
patient
show
rel
high
auc
sensit
specif
cflar
aucvalu
mpp
patient
compar
hc
respect
lower
aucvalu
compar
mpp
idc
patient
respect
addit
combin
hc
idc
analysi
cflar
aucvalu
mpp
compar
hc
plu
idc
respect
result
show
mpp
group
present
best
auc
among
three
protein
compar
hc
idc
hc
combin
idc
use
optim
cutoff
protein
calcul
sensit
specif
combin
two
three
select
protein
differenti
mpp
shown
tabl
although
specif
combin
protein
gener
higher
sensit
combin
protein
lower
best
protein
discrimin
mpp
patient
hc
idc
patient
combin
perform
select
protein
differenti
mpp
result
show
alon
best
choic
children
immun
respons
induc
mp
infect
import
effect
pathogen
mechan
protein
express
tradit
protein
appear
circul
mani
differ
mechan
includ
secret
subject
infect
pathogen
product
stimul
antigen
direct
secret
mp
li
et
al
recent
highthroughput
technolog
use
investig
protein
express
therefor
accur
detect
quantif
mpassoci
protein
use
potenti
diagnost
marker
previou
method
use
detect
mp
limit
daxboeck
et
al
long
et
al
yuta
et
al
katsushima
et
al
clinic
practic
coinfect
common
children
pneumonia
therefor
studi
hc
idc
use
control
use
labelfre
quantit
analysi
analyz
plasma
protein
among
mpp
hc
idc
individu
proteom
approach
allow
measur
chang
protein
express
might
use
forecast
diseas
pathogenesi
report
protein
identifi
mpp
group
compar
hc
idc
group
overlap
addit
wego
use
analysi
function
differ
protein
observ
major
protein
cellular
distribut
organel
mainli
relat
bind
catalysi
enzym
regul
molecular
transduc
transcript
regul
transport
mostli
particip
cellular
process
metabol
process
cellular
compon
organ
biolog
regul
pigment
thought
essenti
pathogenesi
mp
among
protein
identifi
five
potenti
candid
biomark
cflar
select
verif
correl
immun
respons
infecti
diseas
howev
elisa
show
level
cflar
significantli
differ
among
three
group
ratio
consist
trend
proteom
analys
use
optim
cutoff
protein
analyz
sensit
specif
differ
combin
two
three
differ
protein
diagnosi
mpp
specif
combin
protein
gener
higher
sensit
combin
protein
gener
lower
best
protein
differenti
mpp
patient
hc
idc
patient
summari
result
show
alon
best
choic
differenti
mpp
children
best
sensit
specif
best
knowledg
sensit
specif
mpspecif
antigen
current
use
poor
use
diagnost
test
base
ineffect
antibodi
detect
zhang
et
al
li
et
al
use
labelfre
quantit
proteom
demonstr
product
cell
increas
infect
mp
also
found
level
higher
mpp
patient
sensit
specif
accuraci
respect
li
et
al
howev
larger
sampl
size
need
identif
quantif
mp
uniqu
cell
wall
defici
cholesterol
requir
bacteria
et
al
ko
et
al
cholesterol
metabol
essenti
mp
growth
infect
plasma
protein
inhibit
receptormedi
lipoprotein
clearanc
shulman
et
al
secret
mani
organ
includ
liver
spleen
lung
secret
blood
lauer
et
al
therefor
plasma
level
associ
cholesterol
metabol
mp
infect
statu
human
lipid
metabol
one
essenti
chang
mani
infecti
diseas
includ
mpp
katsel
et
al
xiang
et
al
furthermor
mani
cholesterol
metabolit
analyz
studi
aim
screen
identifi
earli
biomark
infecti
diseas
leoni
et
al
bach
et
al
gilch
et
al
sever
gene
associ
cholesterol
metabol
lipid
biosynthesi
report
upregul
serum
plasma
brown
et
al
activ
cholesterol
metabol
barbisin
et
al
upregul
lead
increas
cholesterol
biosynthesi
consist
concomit
presenc
mp
infecti
diseas
studi
demonstr
alon
potenti
biomark
differenti
mpp
children
exploratori
studi
detect
novel
plasma
proteom
biomark
studi
requir
mpp
caus
cap
children
biomark
select
requir
larg
sampl
verif
clearli
focu
investig
conclus
potenti
mpp
plasma
biomark
identifi
use
lcmsm
elisa
verif
identifi
satisfactori
sensit
specif
discrimin
mpp
hc
idc
repres
viabl
approach
differenti
mpp
jl
design
experi
jl
ls
perform
experi
analyz
data
fx
wj
hq
provid
technic
support
experi
jx
cs
provid
comment
technic
advic
jl
ls
wrote
manuscript
jl
bx
ql
revis
manuscript
author
discuss
result
comment
manuscript
agre
account
aspect
work
ensur
question
relat
accuraci
integr
part
work
appropri
investig
resolv
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
